Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.33 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.33 |
| ▸ | MMP2 | P08253 | 2/20 | 0.33 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | RAD52 | P43351 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4940793 | 0.98 | SMN1; SMN2 (0.35) | SMN1; SMN2USP2CYP3A4ALDH1A1PSMD14 | |
| Octanol SCHEMBL25290217 | 0.89 | LMNA (0.52) | SMN1; SMN2ALDH1A1PSMD14PLA2G1BMMP2 | |
| SCHEMBL36865 | 0.87 | — | — | |
| SCHEMBL13894349 | 0.87 | — | — | |
| SCHEMBL12011204 | 0.87 | — | — | |
| SCHEMBL26966568 | 0.85 | THRB (0.46) | SMN1; SMN2USP2CYP3A4ALDH1A1LMNA | |
| SCHEMBL2361319 | 0.84 | THRB (0.48) | SMN1; SMN2USP2CYP3A4LMNATSHR | |
| 1,4-Butanediol SCHEMBL27601018 | 0.84 | SMN1; SMN2 (0.43) | SMN1; SMN2ALDH1A1PSMD14PLA2G1BMMP2 | |
| SCHEMBL18778587 | 0.82 | USP2 (0.33) | SMN1; SMN2USP2CYP3A4ALDH1A1TSHR | |
| SCHEMBL13041137 | 0.82 | ALDH1A1 (0.42) | SMN1; SMN2CYP3A4ALDH1A1TSHRGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 394 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250275536-A1 | Antimicrobial Composition | KAMER, Patrick (CH) | 2025-09-04 | — | — | US | claimed |
| EP-4518653-A1 | ANTIMICROBIAL COMPOSITION | Kamer, Patrick (CH) | 2025-03-12 | — | — | EP | claimed |
| WO-2023213846-A1 | ANTIMICROBIAL COMPOSITION | KAMER PATRICK (CH) | 2023-11-09 | — | — | WO | claimed |
| EP-3303491-B1 | WATERBORNE COATING COMPOSITION | SWIMC LLC (US) | 2021-10-20 | — | — | EP | claimed |
| CN-107810244-B | Aqueous coating composition | 宣伟投资管理有限公司 | 2020-08-18 | — | — | CN | claimed |
| EP-2092018-B1 | LOW ODOR, FAST CURE, TOUGHENED EPOXY ADHESIVE | ASHLAND LICENSING & IP LLC (US) | 2019-02-20 | — | — | EP | claimed |
| EP-3303491-A1 | WATERBORNE COATING COMPOSITION | The Sherwin-Williams Company (US) | 2018-04-11 | — | — | EP | claimed |
| US-9745495-B2 | Waterborne coating composition | THE SHERWIN-WILLIAMS COMPANY (US) | 2017-08-29 | — | — | US | claimed |
| WO-2016196657-A1 | WATERBORNE COATING COMPOSITION | THE SHERWIN-WILLIAMS COMPANY (US) | 2016-12-08 | — | — | WO | claimed |
| US-20160347978-A1 | Waterborne Coating Composition | THE SHERWIN-WILLIAMS COMPANY (US) | 2016-12-01 | — | — | US | claimed |
| US-7745006-B2 | Low odor, fast cure, toughened epoxy adhesive | ASHLAND LICENSING AND INTELLECTUAL PROPERTY, LLC (US) | 2010-06-29 | — | — | US | claimed |
| US-7737199-B2 | enhanced adhesion to sheet molding compound; improved toughness, impact resistance; for use in vehicle assembly | ASHLAND LICENSING & INTELLECTUAL PROPERTY LLC (US) | 2010-06-15 | — | — | US | claimed |
| US-20080199717-A1 | Fast cure epoxy adhesive with enhanced adhesion to toughened sheet molding compound | ARKEMA FRANCE (FR) | 2008-08-21 | — | — | US | claimed |
| US-20080145667-A1 | Low odor, fast cure, toughened epoxy adhesive | ARKEMA FRANCE (FR) | 2008-06-19 | — | — | US | claimed |
| US-12637599-B2 | Two-component polyurethane adhesive composition for film lamination in hot filling application | HENKEL AG & CO. KGAA (DE) | 2026-05-26 | — | — | US | disclosed |
| US-12624126-B2 | Dextran-alpha-glucan graft copolymers and derivatives thereof | Nutrition & Biosciences USA 4, Inc. (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260098119-A1 | FLAME RETARDANT COMPOSITIONS, COMPOUNDS, AND METHODS OF MAKING | FULLER H B CO (US) | 2026-04-09 | — | — | US | disclosed |
| US-4035318-A | BISDIISOCYANATOBENZYLCHLOROBENZENE | OLIN CORPORATION (US) | 1977-07-12 | — | — | US | disclosed |
| US-4008189-A | Hydrophilic polyurethane foam | OLIN CORPORATION (US) | 1977-02-15 | — | — | US | disclosed |
| US-3952043-A | CROSSLINKING AGENTS FOR POLYURETHANES | OLIN CORPORATION (US) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098119-A1 | FLAME RETARDANT COMPOSITIONS, COMPOUNDS, AND METHODS OF MAKING | DSG1, PIEZO1, LRBA | SMN1; SMN2 732/4885USP2 213/4885CYP3A4 2345/4885 |
| US-12637599-B2 | Two-component polyurethane adhesive composition for film lamination in hot filling application | EPHX2, GJB2, GJA1 | SMN1; SMN2 4127/4885USP2 1256/4885CYP3A4 1462/4885 |
| US-20250275536-A1 | Antimicrobial Composition | CUTA, POLR1C, PIK3C3 | SMN1; SMN2 4521/4885USP2 2433/4885CYP3A4 2242/4885 |
| US-12624126-B2 | Dextran-alpha-glucan graft copolymers and derivatives thereof | ALG8, DDOST, ALG1 | SMN1; SMN2 3257/4885USP2 2388/4885CYP3A4 2890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.